AGMT 02/10/11: CONFRONT PAH: CombinatiON up-FRON t Therapy for PAH-A Phase 4, Randomized, Multicenter Study of Inhaled Treprostinil in Treatment-naive Pulmonary Arterial Hypertension Patients Starting on Tadalafil

Project: Research project

Project Details

StatusFinished
Effective start/end date2/10/11 → 2/10/17

Funding

  • United Therapeutics Corporation (AGMT 02/10/11: CONFRONT PAH)